Literature DB >> 30311384

Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework.

Andrew R Grant1, Brandon J Cushman1, Hélène Cavé2, Mitchell W Dillon3, Bruce D Gelb4, Karen W Gripp5, Jennifer A Lee6, Heather Mason-Suares1, Katherine A Rauen7, Marco Tartaglia8, Lisa M Vincent9, Martin Zenker10.   

Abstract

The RASopathies are a complex group of conditions regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel (RAS EP) assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Using the semiquantitative literature curation method developed by the ClinGen Gene Curation Working Group, evidence for each gene was curated and scored for Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome, NS with multiple lentigines, and Noonan-like syndrome with loose anagen hair. The curated evidence supporting each gene-disease relationship was then discussed and approved by the ClinGen RASopathy Expert Panel. Each association's strength was classified as definitive, strong, moderate, limited, disputed, or no evidence. Eleven genes were classified as definitively associated with at least one RASopathy condition. Two genes classified as strong for association with at least one RASopathy condition while one gene was moderate and three were limited. The RAS EP also disputed the association of two genes for all RASopathy conditions. Overall, our results provide a greater understanding of the different gene-disease relationships within the RASopathies and can help in guiding and directing clinicians, patients, and researchers who are identifying variants in individuals with a suspected RASopathy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ClinGen; RASopathy; gene curation; genetic; genomics

Mesh:

Substances:

Year:  2018        PMID: 30311384      PMCID: PMC6326381          DOI: 10.1002/humu.23624

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

1.  PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.

Authors:  Maria I Kontaridis; Kenneth D Swanson; Frank S David; David Barford; Benjamin G Neel
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

2.  Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.

Authors:  Guilherme Lopes Yamamoto; Meire Aguena; Monika Gos; Christina Hung; Jacek Pilch; Somayyeh Fahiminiya; Anna Abramowicz; Ingrid Cristian; Michelle Buscarilli; Michel Satya Naslavsky; Alexsandra C Malaquias; Mayana Zatz; Olaf Bodamer; Jacek Majewski; Alexander A L Jorge; Alexandre C Pereira; Chong Ae Kim; Maria Rita Passos-Bueno; Débora Romeo Bertola
Journal:  J Med Genet       Date:  2015-03-20       Impact factor: 6.318

3.  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.

Authors:  Martin Zenker; Katarina Lehmann; Anna Leana Schulz; Helmut Barth; Dagmar Hansmann; Rainer Koenig; Rudolf Korinthenberg; Martina Kreiss-Nachtsheim; Peter Meinecke; Susanne Morlot; Stefan Mundlos; Anne S Quante; Salmo Raskin; Dirk Schnabel; Lars-Erik Wehner; Christian P Kratz; Denise Horn; Kerstin Kutsche
Journal:  J Med Genet       Date:  2006-10-20       Impact factor: 6.318

4.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Authors:  Marco Tartaglia; Kamini Kalidas; Adam Shaw; Xiaoling Song; Dan L Musat; Ineke van der Burgt; Han G Brunner; Débora R Bertola; Andrew Crosby; Andra Ion; Raju S Kucherlapati; Steve Jeffery; Michael A Patton; Bruce D Gelb
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

5.  Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders.

Authors:  A-M Nyström; S Ekvall; E Berglund; M Björkqvist; G Braathen; K Duchen; H Enell; E Holmberg; U Holmlund; M Olsson-Engman; G Annerén; M-L Bondeson
Journal:  J Med Genet       Date:  2008-05-02       Impact factor: 6.318

6.  Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.

Authors:  Alessandra Fragale; Marco Tartaglia; Jie Wu; Bruce D Gelb
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

7.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.

Authors:  Caroline Nava; Nadine Hanna; Caroline Michot; Sabrina Pereira; Nathalie Pouvreau; Tetsuya Niihori; Yoko Aoki; Yoichi Matsubara; Benoit Arveiler; Didier Lacombe; Eric Pasmant; Béatrice Parfait; Clarisse Baumann; Delphine Héron; Sabine Sigaudy; Annick Toutain; Marlène Rio; Alice Goldenberg; Bruno Leheup; Alain Verloes; Hélène Cavé
Journal:  J Med Genet       Date:  2007-08-17       Impact factor: 6.318

8.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.

Authors:  Tetsuya Niihori; Yoko Aoki; Yoko Narumi; Giovanni Neri; Hélène Cavé; Alain Verloes; Nobuhiko Okamoto; Raoul C M Hennekam; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Maria Ines Kavamura; Kenji Kurosawa; Hirofumi Ohashi; Louise Wilson; Delphine Heron; Dominique Bonneau; Giuseppina Corona; Tadashi Kaname; Kenji Naritomi; Clarisse Baumann; Naomichi Matsumoto; Kumi Kato; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

9.  Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations.

Authors:  Kimihiko Oishi; Konstantin Gaengel; Srinivasan Krishnamoorthy; Kenichi Kamiya; In-Kyong Kim; Huiwen Ying; Ursula Weber; Lizabeth A Perkins; Marco Tartaglia; Marek Mlodzik; Leslie Pick; Bruce D Gelb
Journal:  Hum Mol Genet       Date:  2006-01-06       Impact factor: 6.150

10.  Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations.

Authors:  Zhi-Hong Yu; Ruo-Yu Zhang; Chad D Walls; Lan Chen; Sheng Zhang; Li Wu; Sijiu Liu; Zhong-Yin Zhang
Journal:  Biochemistry       Date:  2014-06-17       Impact factor: 3.162

View more
  24 in total

1.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

2.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

Review 3.  Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.

Authors:  Victoria L Patterson; Rebecca D Burdine
Journal:  Birth Defects Res       Date:  2020-06-07       Impact factor: 2.344

4.  SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.

Authors:  Marialetizia Motta; Giulia Fasano; Sina Gredy; Julia Brinkmann; Adeline Alice Bonnard; Pelin Ozlem Simsek-Kiper; Elif Yilmaz Gulec; Leila Essaddam; Gulen Eda Utine; Ingrid Guarnetti Prandi; Martina Venditti; Francesca Pantaleoni; Francesca Clementina Radio; Andrea Ciolfi; Stefania Petrini; Federica Consoli; Cédric Vignal; Denis Hepbasli; Melanie Ullrich; Elke de Boer; Lisenka E L M Vissers; Sami Gritli; Cesare Rossi; Alessandro De Luca; Saayda Ben Becher; Bruce D Gelb; Bruno Dallapiccola; Antonella Lauri; Giovanni Chillemi; Kai Schuh; Hélène Cavé; Martin Zenker; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2021-10-08       Impact factor: 11.025

5.  Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.

Authors:  George Papadopoulos; Anna Papadopoulou; Konstantina Kosma; Anastasios Papadimitriou; Vassiliki Papaevangelou; Christina Kanaka-Gantenbein; Evangelia Bountouvi; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2022-07-29       Impact factor: 3.860

Review 6.  LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.

Authors:  Kirsten M Farncombe; Emily Thain; Carolina Barnett-Tapia; Hamid Sadeghian; Raymond H Kim
Journal:  BMC Med Genomics       Date:  2022-07-15       Impact factor: 3.622

Review 7.  Lymphatic Abnormalities in Noonan Syndrome Spectrum Disorders: A Systematic Review.

Authors:  Julia Sleutjes; Lotte Kleimeier; Erika Leenders; Willemijn Klein; Jos Draaisma
Journal:  Mol Syndromol       Date:  2021-09-10

8.  Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students.

Authors:  Megan E Grove; Shana White; Dianna G Fisk; Shannon Rego; Orit Dagan-Rosenfeld; Jennefer N Kohler; Chloe M Reuter; Devon Bonner; Matthew T Wheeler; Jonathan A Bernstein; Kelly E Ormond; Andrea K Hanson-Kahn
Journal:  J Genet Couns       Date:  2019-02-01       Impact factor: 2.537

Review 9.  Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution.

Authors:  Zornitza Stark; Rebecca E Foulger; Eleanor Williams; Bryony A Thompson; Chirag Patel; Sebastian Lunke; Catherine Snow; Ivone U S Leong; Arina Puzriakova; Louise C Daugherty; Sarah Leigh; Christopher Boustred; Olivia Niblock; Antonio Rueda-Martin; Oleg Gerasimenko; Kevin Savage; William Bellamy; Victor San Kho Lin; Roman Valls; Lavinia Gordon; Helen K Brittain; Ellen R A Thomas; Ana Lisa Taylor Tavares; Meriel McEntagart; Susan M White; Tiong Y Tan; Alison Yeung; Lilian Downie; Ivan Macciocca; Elena Savva; Crystle Lee; Ain Roesley; Paul De Fazio; Jane Deller; Zandra C Deans; Sue L Hill; Mark J Caulfield; Kathryn N North; Richard H Scott; Augusto Rendon; Oliver Hofmann; Ellen M McDonagh
Journal:  Am J Hum Genet       Date:  2021-07-29       Impact factor: 11.025

10.  Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutations.

Authors:  Swarnendu Tripathi; Nikita R Dsouza; Raul Urrutia; Michael T Zimmermann
Journal:  Bioinformatics       Date:  2021-06-16       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.